A NOVEL SUSTAINED-RELEASE FORMULATION OF IBUPROFEN PROVIDES EFFECTIVE ONCE-DAILY THERAPY IN THE TREATMENT OF RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS

被引：0

作者：

OCONNOR, TP

ANDERSON, AMR

LENNOX, B

MULDOON, C

机构：

[1] BOOTS PHARMACEUT,CLIN INVEST,NOTTINGHAM NG2 3AA,ENGLAND

[2] HLTH CTR,PAISLEY,RENFREW,SCOTLAND

[3] ST MARYS HLTH CTR,PRESTON,ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PRACTICE | 1993年 / 47卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The efficacy and safety of a novel sustained-release formulation of ibuprofen given once-daily was compared with conventional-release ibuprofen tablets 400 mg given four times daily, in a single-blind, parallel-group study. This study was conducted at 84 general practice centres throughout the UK among patients with osteoarthritis or rheumatoid arthritis. An unequal randomisation in the ratio of 4:1 was carried out, with 463 patients who received sustained-release and 115 who received conventional-release ibuprofen providing evaluable data. In this study sustained-release ibuprofen was shown to be a more effective alternative to conventional ibuprofen therapy for the treatment of arthritic diseases in general practice, offering the convenience of once-daily dosing and the associated potential benefit of improved patient compliance.

引用

页码：10 / 13

页数：4

共 50 条

[21] A COMPARISON OF A SUSTAINED-RELEASE PREPARATION OF TIAPROFENIC ACID WITH THE CONVENTIONAL TABLET FORMULATION AND A PLACEBO IN RHEUMATOID-ARTHRITIS
ESSIGMAN, W
LAMBERT, J
SHELDON, P
SWEETMAN, BJ
WOJTULEWSKI, J
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1987, 7 (04) : 251 - 257
[22] Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation (vol 4, 61, 2003)
Kasu, Raghu Rami Reddy
Mutalik, Srinivas
Reddy, Srinivas
AAPS PHARMSCITECH, 2020, 21 (05)
[23] ANTIHYPERTENSIVE EFFECT OF VERAPAMIL IN A NEW SUSTAINED-RELEASE PREPARATION FOR A ONCE-DAILY ADMINISTRATION
POZENEL, H
FORTSCHRITTE DER MEDIZIN, 1985, 103 (23) : 639 - 642
[24] PHARMACOKINETICS OF ONCE-DAILY VERAPAMIL - COMPARATIVE BIOAVAILABILITY OF 2 SUSTAINED-RELEASE FORMULATIONS
MUIRHEAD, DC
NORRIS, RJ
COCKAYNE, D
HILL, GWR
BRITISH JOURNAL OF CLINICAL PRACTICE, 1988, 42 (04): : 14 - 19
[25] PHARMACOKINETIC ANALYSIS OF 2 NEW SUSTAINED-RELEASE PRODUCTS OF DILTIAZEM DESIGNED FOR TWICE-DAILY AND ONCE-DAILY TREATMENT
BIALER, M
HADAD, S
GOLOMB, G
BAREL, S
SAMARA, E
ABUSALACH, O
BERKMAN, N
DANENBERG, HD
BENDAVID, J
CARON, D
KAPLAN, R
TAMIR, A
FRIEDMAN, M
BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (01) : 45 - 52
[26] USE OF A SUSTAINED-RELEASE ASPIRIN PREPARATION IN MANAGEMENT OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS
ROTSTEIN, J
ESTRIN, I
CUNNINGHAM, C
GILBERT, M
JORDAN, A
LAMSTEIN, J
SAFRIN, M
WIMER, E
SILSON, J
JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS, 1967, 7 (02): : 97 - +
[27] Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis
Mansfield, Lyndon E.
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (07) : 941 - 951
[28] THEOPHYLLINE THERAPEUTIC DRUG-MONITORING IN THE CASE OF A NEW SUSTAINED-RELEASE PELLET FORMULATION FOR ONCE-DAILY EVENING ADMINISTRATION
STEINIJANS, VW
TRAUTMANN, H
SAUTER, R
STAUDINGER, H
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-2 (8A): : 1251 - 1253
[29] Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: A randomized controlled trial
Beaulieu, Andre D.
Peloso, Paul M.
Haraoui, Boulos
Bensen, William
Thomson, Glen
Wade, John
Quigley, Patricia
Eisenhoffer, John
Harsanyi, Zoltan
Darke, Andrew C.
PAIN RESEARCH & MANAGEMENT, 2008, 13 (02): : 103 - 110
[30] EFFECTIVENESS OF ONCE-DAILY MONOTHERAPY WITH A NEW NIFEDIPINE SUSTAINED-RELEASE CALCIUM-ANTAGONIST
CARR, AA
BOTTINI, PB
FEIG, P
PRISANT, LM
MULLIGAN, S
DEVANE, JG
FISHER, L
RHOADES, RB
MACCARTHY, EP
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (13): : E28 - E32

← 1 2 3 4 5 →